Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 5, Pages 1204-1213
Publisher
Wiley
Online
2013-02-13
DOI
10.1002/ijc.28111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions
- (2015) Martin Michaelis et al. NEOPLASIA
- Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival
- (2013) Afsar Rahbar et al. JOURNAL OF CLINICAL VIROLOGY
- Cytomegalovirus Infection Leads to Pleomorphic Rhabdomyosarcomas in Trp53+/- Mice
- (2012) R. L. Price et al. CANCER RESEARCH
- Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme
- (2012) Tania Crough et al. IMMUNOLOGY AND CELL BIOLOGY
- Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
- (2012) Alexia Ghazi et al. JOURNAL OF IMMUNOTHERAPY
- Genetic Analysis of Cytomegalovirus in Malignant Gliomas
- (2012) B. Bhattacharjee et al. JOURNAL OF VIROLOGY
- Consensus on the role of human cytomegalovirus in glioblastoma
- (2012) K. Dziurzynski et al. NEURO-ONCOLOGY
- Human Cytomegalovirus US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype
- (2011) L. Soroceanu et al. CANCER RESEARCH
- The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
- (2011) J. J. Vredenburgh et al. CLINICAL CANCER RESEARCH
- Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis
- (2011) Michael Melnick et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: Cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship
- (2011) Michael Melnick et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
- (2011) Ninib Baryawno et al. JOURNAL OF CLINICAL INVESTIGATION
- Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples
- (2011) P. Ranganathan et al. JOURNAL OF VIROLOGY
- The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice
- (2010) Gerold Bongers et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6-STAT3 Axis
- (2010) E. Slinger et al. Science Signaling
- Is HCMV a tumor promoter?
- (2010) Liliana Soroceanu et al. VIRUS RESEARCH
- Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy
- (2009) Mary Lou Affronti et al. CANCER
- The Human Cytomegalovirus-Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2
- (2009) D. Maussang et al. CANCER RESEARCH
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started